# A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain

> **NCT01968018** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag Ltd.,Thailand** · enrollment: 35 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Tramadol HCI/acetaminophen

## Key facts

- **NCT ID:** NCT01968018
- **Lead sponsor:** Janssen-Cilag Ltd.,Thailand
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968018, "A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01968018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*